In This Section
Frequently Asked Questions (FAQs) about USP <797>
Prepared by: Joseph C. Hung (Division of Nuclear Medicine, Department of Radiology, Mayo Clinic, Rochester, Minnesota) and James A. Ponto (Section of Nuclear Medicine, Department of Radiology, University of Iowa Hospitals and Clinics)
Disclaimer: These FAQs reflect the authors' views only. They have not been provided or endorsed by the USP <797> Convention or the USP <797> Expert Committee on Sterile Compounding, nor do they necessarily reflect the views of the authors' institutions, SNM, or any other entities. This document is provided for informational purposes only and is not intended as legal advice. It should not be used to replace the advice of your own legal counsel.
These FAQs are also grouped together by topic area, with the following general outline:
- General Questions about USP <797>
- Specific Questions about USP <797>
If you have a question about USP <797> that has not already been answered, please send it to USP797@snmmi.org.
US Pharmacopeia's General Chapter Frequently Asked Questions can be found here.
This is a dynamic document, so please check back often for additional information.